» Articles » PMID: 39266508

Engineered Model of Heart Tissue Repair for Exploring Fibrotic Processes and Therapeutic Interventions

Overview
Journal Nat Commun
Specialty Biology
Date 2024 Sep 12
PMID 39266508
Authors
Affiliations
Soon will be listed here.
Abstract

Advancements in human-engineered heart tissue have enhanced the understanding of cardiac cellular alteration. Nevertheless, a human model simulating pathological remodeling following myocardial infarction for therapeutic development remains essential. Here we develop an engineered model of myocardial repair that replicates the phased remodeling process, including hypoxic stress, fibrosis, and electrophysiological dysfunction. Transcriptomic analysis identifies nine critical signaling pathways related to cellular fate transitions, leading to the evaluation of seventeen modulators for their therapeutic potential in a mini-repair model. A scoring system quantitatively evaluates the restoration of abnormal electrophysiology, demonstrating that the phased combination of TGFβ inhibitor SB431542, Rho kinase inhibitor Y27632, and WNT activator CHIR99021 yields enhanced functional restoration compared to single factor treatments in both engineered and mouse myocardial infarction model. This engineered heart tissue repair model effectively captures the phased remodeling following myocardial infarction, providing a crucial platform for discovering therapeutic targets for ischemic heart disease.

Citing Articles

Advances in cardiac organoid research: implications for cardiovascular disease treatment.

Huang Z, Jia K, Tan Y, Yu Y, Xiao W, Zhou X Cardiovasc Diabetol. 2025; 24(1):25.

PMID: 39827092 PMC: 11743075. DOI: 10.1186/s12933-025-02598-8.

References
1.
Westendorp B, Mokry M, Groot Koerkamp M, Holstege F, Cuppen E, de Bruin A . E2F7 represses a network of oscillating cell cycle genes to control S-phase progression. Nucleic Acids Res. 2011; 40(8):3511-23. PMC: 3333892. DOI: 10.1093/nar/gkr1203. View

2.
Pillai I, Li S, Romay M, Lam L, Lu Y, Huang J . Cardiac Fibroblasts Adopt Osteogenic Fates and Can Be Targeted to Attenuate Pathological Heart Calcification. Cell Stem Cell. 2016; 20(2):218-232.e5. PMC: 5291784. DOI: 10.1016/j.stem.2016.10.005. View

3.
Piamsiri C, Maneechote C, Siri-Angkul N, Chattipakorn S, Chattipakorn N . Targeting necroptosis as therapeutic potential in chronic myocardial infarction. J Biomed Sci. 2021; 28(1):25. PMC: 8034148. DOI: 10.1186/s12929-021-00722-w. View

4.
Cadenas S . Mitochondrial uncoupling, ROS generation and cardioprotection. Biochim Biophys Acta Bioenerg. 2018; 1859(9):940-950. DOI: 10.1016/j.bbabio.2018.05.019. View

5.
Li C, Liu Z, Xu Q, Peng H, Cao J, Zhou H . PXDN reduces autophagic flux in insulin-resistant cardiomyocytes via modulating FoxO1. Cell Death Dis. 2021; 12(5):418. PMC: 8076187. DOI: 10.1038/s41419-021-03699-4. View